Why Linking Tech in European Clinical Research Studies is Critical for 2023

Join our expert panel for a discussion to gain insight into the critical trends coming to Europe in 2023.

What does it mean to be a sponsor of choice?

Real-world Evidence, How Integrated Tech Makes Things Happen

Successfully Implementing New Technology

This session will explore what strategies Florence's implementation team uses to ensure a successful implementation with customers.

From Traditional to Digital Site Collaboration

Selecting Patient-facing Technology that Actually Works

Leading experts will discuss how to select and evaluate technology that will be used by patients in this session.

Become a Sponsor/CRO of Choice Through eConsent

Learn about the future of consenting, how focusing on patient engagement drives decisions for Sponsor of Choice, and the critical features you don't want to leave out of your eConsent tool.

Sites, DCTs, and Agile Trials... How Do They All Mix?

Emerging Business Models in Clinical Research as a Result of Technology Innovation

How Can Sites Collaborate with Sponsors to Increase Access to Clinical Trials

GDPR, EMRA, CFR, CCPA… Going Global in an Increasingly Regulated World

Going Digital: Patient Engagement and Your Consent Workflow

Whether you’ve already gone digital, or are just starting to transition, join us as we dive into the future of consenting.

Designing More Diverse and Inclusive Trials

The Future of Site and Sponsor Collaboration Through Technology

Linking to the Site's eISF: Why It Matters and How to Do It

How Sponsors & CROs can start-up and collaborate with “frontier” sites

Too Many Trials, Too Few CRAs - Maximizing CRA Efficiency

Breaking Down the FDA's 2022 Guidance on Diversity

Learn from Catherine Gregor about the newly published FDA draft guidance for increasing participant enrollment from underrepresented racial and ethnic groups in clinical trials.

Florence eConsent - An Interview with Mason McLellan at OHSU Knight Cancer Institute

Florence eConsen: An Interview with Mason McLellan with CEDAR at OHSU Knight Cancer Institute sharing why their organization moved to eConsent, how they did it and the impact it’s making.